Apple shares fall 2.8% as smartphone sales decline 24% in China. Plus, shares of several dialysis companies rise after a study shows Ozempic did not cut the risk of kidney disease-related events in diabetic patients by as much as investors expected. J.R. Whalen reports.

Learn more about your ad choices. Visit megaphone.fm/adchoices